The Effect of The Five-Session Dual-tDCS On Lower-Limb Performance in Sub-Acute Stroke (NCT04287231) | Clinical Trial Compass
CompletedNot Applicable
The Effect of The Five-Session Dual-tDCS On Lower-Limb Performance in Sub-Acute Stroke
Thailand24 participantsStarted 2019-08-19
Plain-language summary
The aim of the present study is to determine the effect of the five-session dual-tDCS combine with physical therapy on gait performance, balance and lower limbs muscle strength in patients with subacute stroke.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age range 20-75 years
* First ever-ischemic lesion in the territory of middle cerebral artery or anterior cerebral artery. Diagnostic confirmation will be performed by CT scan or MRI
* Sub-acute onset (1-6 months after the stroke onset)
* Able to walk without physical assistance at least 6 meters
Exclusion Criteria:
* All subjects will be excluded from the study if they have:
* Not cooperative or cannot understand the instruction
* Clinical unstable such as vital sign unstable (systolic blood pressure (SBP) ≥ 185 mmHg or diastolic blood pressure (DBP) ≥ 110 mmHg (98) and resting heart rate averaging ≥ 100 bpm (99))
* No clear neurological antecedent history or psychiatric disorder
* Moderate pain in any joint of both lower limb (Pain Scale (VAS) ≥ 4/10)
* Unstable medical conditions such as being in the middle of changing medical treatment.
* Condition that may increase the risk of stimulation such as epilepsy, pregnancy, unexplained headaches, intracranial metal, pacemaker (evaluating by subjective examination).
* Participate in the other protocol or receive alternative treatment such as transcranial magnetic stimulation within 1 month.
What they're measuring
1
Force distribution measurement (FDM; The WinFDM and platform, Zebris Medical GmbH, Germany)